Results 131 to 140 of about 5,406 (200)

Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. [PDF]

J Zhejiang Univ Sci B
Wang Y, Gao J, Cheng Y, Pan H, Tang H, Liu C.   +5 more
europepmc   +1 more source

Innovative Tools and Perspectives in Cough Management: Cancer and Cough. [PDF]

Tuberc Respir Dis (Seoul)
Choi J, Lee SY.
europepmc   +1 more source

Enhanced Recovery for Patients Undergoing Metabolic Bariatric Surgery in a Community Hospital: A Retrospective Pre-Post Quality Improvement Study. [PDF]

Obes Surg
Trotter R, Shanks L, Brown H, Miranda AM.   +3 more
europepmc   +1 more source

The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use. [PDF]

Front Pharmacol
Yamaoka K, Kajita S, Kume M, Hirabatake M, Sato Y, Hashida T, Tachikawa R, Muroi N.   +7 more
europepmc   +1 more source

Targeting sirtuin 1/nuclear factor erythroid 2-related factor 2/tumor necrosis factor-α pathway to modulate hepatic ischemia reperfusion-induced injury. [PDF]

World J Hepatol
Kelleni MT, Abdelzaher WY, Adly M, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Prophylaxis and treatment of postoperative nausea and vomiting. [PDF]

BJA Educ
Kovac A, Choksi N.
europepmc   +1 more source

RETRACTION: "Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres". [PDF]

Biomed Res Int
Research International B.
europepmc   +1 more source

Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]

J Natl Cancer Inst
Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK, Støer NC, Bhargava S, Ursin G, Gandini S, Sloan EK, Chang A.   +10 more
europepmc   +1 more source

Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]

Medicine (Baltimore)
Chen F, Cai D, Wen H, Zhang L.
europepmc   +1 more source

Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]

J Minim Invasive Surg
Bala S, Meshram TM, Bhatia P, Rathod D, Kaur M, Kumari K.   +5 more
europepmc   +1 more source